News
3 No-Brainer Stocks to Buy for Under $100 Right Now
Benjamin Franklin would probably be disappointed that the $100 bill that bears his likeness isn't worth what it used to be. However, there are actually plenty of great stocks to be found that you
Want $1 Million in Retirement? Invest $250,000 in These 3 Stocks and Wait a Decade
Sometimes, the old financial adages are spot on. For example, it does take money to make money. And the expression that "time is money" is correct in many ways.
But it's also true that some
Why AbbVie Stock Fell Today
Shares of AbbVie (NYSE: ABBV) were down 5.4% as of 2:00 p.m. ET Friday, even after the pharmaceuticals giant announced slightly better-than-expected quarterly results and raised its full-year
AbbVie (ABBV) Q3 2023 Earnings Call Transcript
Image source: The Motley Fool.
AbbVie (NYSE: ABBV)Q3 2023 Earnings CallOct 27, 2023, 9:00 a.m. ET
Operator
Source Fool.com
2 Green Flags and 1 Red Flag for Novartis Stock
Share prices of Swiss pharmaceutical company Novartis (NYSE: NVS) have climbed more than 10% so far this year. The company focuses on cardiovascular, immunology, neuroscience, solid tumors, and
EQS-News: STRATEC REPORTS RESULTS FOR FIRST NINE MONTHS OF 2023
DexCom (DXCM) Q3 2023 Earnings Call Transcript
Image source: The Motley Fool.
DexCom (NASDAQ: DXCM)Q3 2023 Earnings CallOct 26, 2023, 4:30 p.m. ET
Operator
Source Fool.com
Why Blueprint Medicines Stock Soared Today
Shares of Blueprint Medicines (NASDAQ: BPMC) closed up 25.6% on Thursday after the cancer and blood discorder therapy company announced stronger-than-expected quarterly results.
Blueprint Medicines'
Acadia Healthcare Welcomes Dr. Patrice A. Harris, MD, MA as Independent Director
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that Dr. Patrice A. Harris, MD, MA has been appointed to the Company’s Board of Directors effective October 26, 2023.
This press
Why Novocure Stock Was Sick Today
Oncology-focused healthcare company Novocure (NASDAQ: NVCR) wasn't much of a cure for anyone's ill finances on Thursday. Its share price dived by nearly 8% on the day after management released its
Merck (MRK) Q3 2023 Earnings Call Transcript
Image source: The Motley Fool.
Merck (NYSE: MRK)Q3 2023 Earnings CallOct 26, 2023, 9:00 a.m. ET
Operator
Source Fool.com
Why Rivian Stock Dropped Again Today
Rivian Automotive (NASDAQ: RIVN) shares continued a downward slide today. With a drop of 4.7% as of 12:15 p.m. ET, Rivian stock has plummeted over 35% in the last three months.
Today's drop comes
Beat the Dow Jones With UnitedHealth Group Stock
If you want to beat the market, the key is having strong stocks in your portfolio of businesses that are profitable and growing. One name that has routinely outperformed the markets is health
2 Best Healthcare Stocks to Buy Right Now
The healthcare industry may not be as hot with investors as artificial intelligence or other high-flying industries, but the range of essential needs these businesses serve provides opportunities
Got $1,000? These 2 Stocks Could Be Bargain Buys for 2023 and Beyond
While equity markets this year have recovered some of ground lost from the plunge of 2022, plenty of companies are still struggling. Some of them, though, clearly have the tools to rebound
3 Pharma Stocks That Are Screaming Buys in October
It hasn't been the easiest of years for Johnson & Johnson (NYSE: JNJ), Amgen (NASDAQ: AMGN) and Gilead Sciences (NASDAQ: GILD). Shares of all three healthcare companies are trading flat or down amid
2 Absurdly Cheap Healthcare Stocks to Buy and Hold for Decades
Investing in healthcare can be an excellent way to focus on stable, long-term growth opportunities. And many top healthcare stocks also pay dividends. Two of the best healthcare stocks to buy right
Vertex Pharmaceuticals: Buy at the High?
Vertex Pharmaceuticals (NASDAQ: VRTX) has climbed in the double digits this year and is trading around its highest ever. There are plenty of reasons for this top performance. The company continues
3 Healthcare Stocks to Buy and Hold for the Next 10 Years
It hasn't been the easiest time for investors across a range of industries and sectors over the last few years. The good news is that when you're buying stocks to hold onto for anywhere from five
Why Alkermes Stock Is Sinking Today
Shares of Alkermes (NASDAQ: ALKS) were sinking 7.9% as of 11:58 a.m. ET on Wednesday and had fallen as much as 13.1% earlier in the session. The decline came after the Ireland-based drugmaker
Should Dividend Stock Investors Buy AT&T Stock Right Now?
Fool.com contributor Parkev Tatevosian reviews AT&T's (NYSE: T) latest quarterly update and lets you know if passive income investors should buy the stock.
*Stock prices used were the afternoon
Stock-Split Watch: Could These 2 Growth Stocks Be Next?
Over the past few years, we have witnessed several high-profile stock splits. Of course, these moves don't fundamentally change the value of a corporation. However, they can generate some buzz and
3 Red-Hot Growth Stocks That Are Still Cheap Buys
Are you looking for some exciting growth stocks to put in your portfolio? While some stocks may have risen to absurd valuations, there are still deals out there, especially for long-term investors
Pfizer's Dividend Yield Is Now 5%. Is the Stock a No-Brainer Buy for Income Investors?
Did you know that if you have a high-yielding dividend stock that pays 5%, investing just $20,000 would be enough to generate $1,000 in annual dividend income? High-yielding stocks can be extremely
2 Biotech Stocks You Can Buy and Hold for the Next Decade
There is no denying that the biotech industry can be pretty risky and volatile, but there are also advantages to investing in stocks in this sector. First, there is always a need for innovative